BCEL insider filings

Atreca, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-04-17. Screen BCEL transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for BCEL between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Atreca, Inc.

FiledFormInsiderReported transactionsSource
2024-04-174Orwin John A — PRESIDENT & CEO, DirectorPurchase (P): 1 @ $0.01EDGAR
2024-04-034Courtney Phillips — GENERAL COUNSEL & SECRETARYSale (S): 7,061 @ $0.37EDGAR
2024-04-034Orwin John A — PRESIDENT & CEO, DirectorSale (S): 22,951 @ $0.37EDGAR
2024-04-034Serafini Tito — DirectorSale (S): 20,788 @ $0.07EDGAR
2024-04-034Serafini Tito — DirectorSale (S): 8,393 @ $0.37EDGAR
2023-10-234BAKER BROS. ADVISORS LP
BAKER JULIAN
BAKER FELIX
Baker Bros. Advisors (GP) LLC
Sale (S): 22,837 @ $0.40 · Sale (S): 251,902 @ $0.40EDGAR
2023-08-044Gould Stephen E — Chief Scientific OfficerSale (S): 4,076 @ $0.95EDGAR
2023-08-044Courtney Phillips — General Counsel & SecretarySale (S): 4,076 @ $0.95EDGAR
2023-08-044Serafini Tito — Chief Strategy Officer, DirectorSale (S): 5,487 @ $0.95EDGAR
2023-08-044CROSS HERB — Chief Financial OfficerSale (S): 5,487 @ $0.95EDGAR
2023-06-154Rolfe Lindsey — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2023-06-154Robinson William Hewitt — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2023-06-154Ma Stacey — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2023-06-154Lacey David L. — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2023-06-154Brady Stephen R — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2023-06-154BERGER FRANKLIN M — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2023-06-154ATWOOD BRIAN G — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2023-06-154BALL KRISTINE M — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2023-02-134Courtney Phillips — General Counsel & SecretaryGrant/award (A): 32,500 @ $0 · Grant/award (A): 130,000 (derivative) @ $0EDGAR
2023-02-134Gould Stephen E — Chief Scientific OfficerGrant/award (A): 32,500 @ $0 · Grant/award (A): 130,000 (derivative) @ $0EDGAR
2023-02-134Orwin John A — President & CEO, DirectorGrant/award (A): 435,000 (derivative) @ $0EDGAR
2023-02-134Serafini Tito — Chief Strategy Officer, DirectorGrant/award (A): 43,750 @ $0 · Grant/award (A): 175,000 (derivative) @ $0EDGAR
2023-02-134CROSS HERB — Chief Financial OfficerGrant/award (A): 43,750 @ $0 · Grant/award (A): 175,000 (derivative) @ $0EDGAR
2023-01-114Bishop Philippe C — Chief Medical OfficerGrant/award (A): 350,000 (derivative) @ $0EDGAR
2022-09-204Courtney Phillips — General Counsel & SecretarySale (S): 6,432 @ $1.78EDGAR
2022-09-204Orwin John A — President & CEO, DirectorSale (S): 20,908 @ $1.78EDGAR
2022-09-204Serafini Tito — Chief Strategy Officer, DirectorSale (S): 7,646 @ $1.78EDGAR
2022-09-204CROSS HERB — Chief Financial OfficerSale (S): 7,646 @ $1.78EDGAR
2022-06-304Serafini Tito — Chief Strategy Officer, DirectorSale (S): 15,000 @ $2.02EDGAR
2022-06-174Gould Stephen E — Chief Scientific OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR
2022-06-154Courtney Phillips — General Counsel & SecretaryGrant/award (A): 80,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) @ $0 · Grant/award (A): 45,000 (derivative) · Disposition to issuer (D): 45,000 (derivative) @ $0 · Grant/award (A): 91,666 (derivative) · Disposition to issuer (D): 91,666 (derivative) @ $0 · +2 moreEDGAR
2022-06-154Orwin John A — President & CEO, DirectorGrant/award (A): 260,000 (derivative) · Disposition to issuer (D): 260,000 (derivative) @ $0 · Grant/award (A): 241,000 (derivative) · Disposition to issuer (D): 241,000 (derivative) @ $0 · Grant/award (A): 148,754 (derivative) · Disposition to issuer (D): 148,754 (derivative) @ $0 · +2 moreEDGAR
2022-06-154Serafini Tito — Chief Strategy Officer, DirectorGrant/award (A): 95,000 (derivative) · Disposition to issuer (D): 95,000 (derivative) @ $0 · Grant/award (A): 88,000 (derivative) · Disposition to issuer (D): 88,000 (derivative) @ $0 · Grant/award (A): 141,395 (derivative) · Disposition to issuer (D): 141,395 (derivative) @ $0 · +2 moreEDGAR
2022-06-154CROSS HERB — Chief Financial OfficerGrant/award (A): 95,000 (derivative) · Disposition to issuer (D): 95,000 (derivative) @ $0 · Grant/award (A): 224,999 (derivative) · Disposition to issuer (D): 224,999 (derivative) @ $0 · Grant/award (A): 97,000 (derivative) · Disposition to issuer (D): 97,000 (derivative) @ $0EDGAR
2022-06-134ATWOOD BRIAN G — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2022-06-104Brady Stephen R — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2022-06-104Lacey David L. — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2022-06-104Ma Stacey — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2022-06-104Rolfe Lindsey — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2022-06-104Robinson William Hewitt — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2022-06-104BERGER FRANKLIN M — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2022-06-104BALL KRISTINE M — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2022-03-084Serafini Tito — Chief Strategy Officer, DirectorSale (S): 30,000 @ $5EDGAR
2021-12-284Courtney Phillips — General Counsel & SecretaryGrant/award (A): 80,000 (derivative) @ $0EDGAR
2021-12-284Orwin John A — President & CEO, DirectorGrant/award (A): 260,000 (derivative) @ $0EDGAR
2021-12-284Serafini Tito — Chief Strategy Officer, DirectorGrant/award (A): 95,000 (derivative) @ $0EDGAR
2021-12-284CROSS HERB — Chief Financial OfficerGrant/award (A): 95,000 (derivative) @ $0EDGAR
2021-09-284Serafini Tito — Chief Strategy Officer, DirectorGift (G): 50,000 @ $0 · Gift (G): 50,000 @ $0 · Sale (S): 30,000 @ $6.58EDGAR
2021-09-134Serafini Tito — Chief Strategy Officer, DirectorGrant/award (A): 42,200 @ $0EDGAR
2021-09-134CROSS HERB — Chief Financial OfficerGrant/award (A): 42,200 @ $0EDGAR

Recent 8-K events — Atreca, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-03-118-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-02-068-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-268-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-09-218-K1.02 — Termination of a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-09-148-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2023-08-108-K2.02 — Results of Operations and Financial Condition
?
9.01 — Financial Statements and Exhibits
EDGAR
2023-06-158-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2023-05-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-298-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=BCEL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs